The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(5-Chloro-2-propoxybenzyl)-N-(4-(N-(prop-2-yn-1-yl)sulfamoyl)phenethyl)-2-(thiophen-3-yl)acetamide ID: ALA4559751
Cas Number: 2454246-18-3
PubChem CID: 139600339
Product Number: Y420012, Order Now?
Max Phase: Preclinical
Molecular Formula: C27H29ClN2O4S2
Molecular Weight: 545.13
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C#CCNS(=O)(=O)c1ccc(CCN(Cc2cc(Cl)ccc2OCCC)C(=O)Cc2ccsc2)cc1
Standard InChI: InChI=1S/C27H29ClN2O4S2/c1-3-13-29-36(32,33)25-8-5-21(6-9-25)11-14-30(27(31)17-22-12-16-35-20-22)19-23-18-24(28)7-10-26(23)34-15-4-2/h1,5-10,12,16,18,20,29H,4,11,13-15,17,19H2,2H3
Standard InChI Key: SFPYRFRNYALLHS-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 38 0 0 0 0 0 0 0 0999 V2000
9.2904 -28.8287 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8859 -28.1188 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.4728 -28.8261 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1757 -26.8989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4661 -26.4857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7572 -26.8961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7565 -27.7155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4707 -28.1227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1768 -27.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0456 -26.4829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3335 -26.8950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6261 -26.4818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9139 -26.8940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2024 -26.4807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2066 -25.6596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4959 -25.2506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7827 -25.6587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7847 -26.4842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4960 -26.8937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4988 -27.7150 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6004 -27.7106 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6021 -26.8892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3147 -26.4779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0197 -26.0634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4969 -24.4334 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.2078 -28.1212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2106 -28.9384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9196 -29.3446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6278 -25.6646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3363 -25.2574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9209 -25.2546 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3379 -24.4402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0005 -23.9569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7496 -23.1792 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.9323 -23.1776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6783 -23.9543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
6 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
19 20 1 0
9 2 1 0
2 21 1 0
21 22 1 0
22 23 1 0
23 24 3 0
16 25 1 0
20 26 1 0
26 27 1 0
27 28 1 0
12 29 1 0
29 30 1 0
29 31 2 0
30 32 1 0
32 33 2 0
33 34 1 0
34 35 1 0
35 36 2 0
36 32 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 545.13Molecular Weight (Monoisotopic): 544.1257AlogP: 4.92#Rotatable Bonds: 13Polar Surface Area: 75.71Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.13CX Basic pKa: ┄CX LogP: 5.15CX LogD: 5.15Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.31Np Likeness Score: -2.13
References 1. Jiang Y, He L, Green J, Blevins H, Guo C, Patel SH, Halquist MS, McRae M, Venitz J, Wang XY, Zhang S.. (2019) Discovery of Second-Generation NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization., 62 (21): [PMID:31626545 ] [10.1021/acs.jmedchem.9b01155 ] 2. Xu Y, Xu Y, Blevins H, Guo C, Biby S, Wang XY, Wang C, Zhang S.. (2022) Development of sulfonamide-based NLRP3 inhibitors: Further modifications and optimization through structure-activity relationship studies., 238 [PMID:35635948 ] [10.1016/j.ejmech.2022.114468 ]